Previous human studies demonstrated that lead exposure may modify the metabolism of catecholamines and of hormones controlled by the hypothalamo-pituitary axis and may affect the kallikrein-kinin system. This paper reports unpublished data on the plasma renin activity of leadexposed workers; these results are in agreement with those of previous human and experimental studies suggesting that the synthesis or release of renin is increased after short and moderate exposure to inorganic lead and reduced whenever the exposure is prolonged.
exposed men and was low or absent in old, hypertensive and/or nephropathic lead-exposed subjects (4, 5) . In 22 hospitalized lead-exposed workers, there was a weak but statistically significant correlation between urinary kallikrein activity and plasma renin activity (PRA) (5) .
The present study describes all the cases of leadexposed workers hospitalized at Catholic University of Rome, in which PRA was determined with previously described procedures (5) . PRA was determined in 34 workers and in 21 control subjects both in the supine position and after 1 hr of programmed activity in the upright position. The workers were divided into four groups, on the basis of their age and length of exposure to inorganic or tetraethyl lead: group 1, 15 workers younger than 38 years with exposure to inorganic lead for less than 8 years; group 2, 4 workers older than 42 years with short exposure to inorganic lead; group 3, 8 workers older than 42 years and exposed for more than 12 years to inorganic lead; group 4, 7 men employed for more than 8 years in a factory producing tetraethyl lead.
In the subjects examined, 24-hr urine 6-aminolevulinic acid and lead excretion rates, before and after a 3-day versenate treatment, were determined; renal (8) (9) (10) , but also on peripheral vascular receptors (11) (12) (13) , on the sympathetic nervous system (11) (12) , and on myocardial contractility (11) (12) (13) (14) .
In previous studies (11, 12) increasing inotropism) were more evident. Responses to the higher doses of epinephrine (acting on both aand J8-adrenoreceptors, increasing BP and dP/dt) were unmodified in relation to the controls. In the exposed rats the pressor responses to angiotensin II were increased; responses to angiotensin I, which is transformed to angiotensin II by angiotensin converting enzyme, were unchanged, suggesting a possible inhibition of this enzyme. In the exposed animals, bilateral carotid occlusion, which stimulates afferent baroreflex pathways, induced lower effects on BP and dP/dt than in the controls. In the lead-exposed rats, hexamethonium (a blocker of the sympathetic post- Pressor, inotropic, and chronotropic responses were determined following IV injection of the following substances: phenylephrine (10 ,ug/kg, Sigma); isoprenaline (0.625 jg/kg, Merck); dopamine (12.5 jig/kg, Merck); IV infusion of clonidine (25 ,ug/kg, Boehringer Ingelheim); cocaine (2.5 mg/kg, Angelini); angiotensin I and II (0.50 jig/kg, Sigma) before and 30 min after IP administration of captopril (5 mg/kg; Squibb); papaverine (2 mg/kg, Merck); verapamil (125 jg/kg, Knoll AG); and dibutyryl adenosine 3'-5'-monophosphate (dBcAMP, 5 mg/kg; Fluka AG). All drugs were dissolved in 0.9% saline solution and were injected in a volume of 25 jiL over a period of 5 sec (with the exception of clonidine administered by IV infusion over a 2-min period and captopril administered IP). The catheter was flushed with 50 ,uL of 0.9% saline solution. All doses of the administered substances were expressed in terms of free bases and peak responses were considered.
Blood samples were collected for the determination of lead. The animals were killed by exsanguination and organs were excised for determining the lead content (referred to as the wet weight) and for histological examination. Lead content of blood and organs was determined by atomic absorption spectrophotometry (16) .
The statistical comparison of the data was made by Dunnett's t-test for multiple comparison.
Results
Throughout the exposure period, body weight and general appearance of the animals were not modified by the lead exposure. Lead was increased in blood, kidney, and brain of the treated rats at levels related to the administered dose of the metal ( Table 2 ).
The rats receiving 15 ppm of lead did not demonstrate any modification of the basal cardiovascular parameters (Fig. 1) . Diastolic BP was significantly augmented in the rats receiving 30 ppm of lead; the animals treated with 60 ppm of lead presented increases of both systolic and diastolic BP, of the dP/dt, but not of the heart rate.
In the rats receiving 15 ppm lead, only the pressor responses to angiotensin I and to dibutyryl-cAMP were modified (Table 3 ). All the exposed rats showed similar, reduced BP responses to angiotensin I, but not to angiotensin II. Captopril, an inhibitor of the angiotensin I converting enzyme, produced similar decreases in both control and exposed animals (about 20 mm Hg); however, captopril did not modify the responses to angiotensin I and II in the rats receiving 15 ppm of lead, although it reduced the pressor responses to the same agonists in the animals treated with the higher doses of lead. In all the exposed rats, dibutyryl-cAMP, which enters cardiac and vascular muscle cells, induced a hypotensive response. Dibutyryl-cAMP provoked an increase of BP in the controls. In the rats exposed to 30 and 60 ppm of lead, the hypotensive responses to isoprenaline, a Pl12-adrenoceptor agonist, were potentiated, and the moderate hypertensive responses to dopamine were reversed. In the rats receiving 60 ppm lead, the hypertensive effects induced by tyramine (releasing the labile pool of norepinephrine from the axonal postganglionic adrenergic terminals) were reduced; the hypotensive effects of clonidine (which reduces the sympathetic tone, principally by stimulating X2-adrenoreceptors of central sympathetic junctions) were potentiated. On the other hand, the cardiovascular responses to each of the following pharmacologic agents were not modified by lead exposure: phenylephrine (a specific xl-adrenoreceptor agonist); papaverine (a smooth muscle relaxant that inhibits the phosphodiesterase); cocaine (a blocker of the neuronal uptake of noradrenaline); and verapamil (a calcium antagonist that inhibits both in myocardial and vascular muscle cells the slow influx of calcium through receptor operated channels). In the exposed rats, heart rate was not modified by these substances. Histological examination by light microscopy did not reveal alterations in the organs of the exposed rats.
Discussion
This study confims that long-term exposure of rats to lead is able to increase both blood pressure and cardiac inotropism without morphological modifications, as observed by light microscopy.
The reduced responses to angiotensin I, but not to angiotensin II, in the lead-exposed rats may be explained by a possible inhibition of the converting enzyme and/or by an increase in plasma renin activity augmenting the level of angiotensin I in the plasma. The reduced responses to angiotensin I and II after captopril in the rats receiving higher doses of lead may be related to an effect of the metal on the mechanisms involved in the homeostatic regulation of the renin-angiotensin system.
The increased hypotensive response to clonidine, resulting from stimulation of the a2-adrenoreceptors (13), also with inhibition of the release of norepinephrine from the central sympathetic axonal endings, indicates that the increase of the sympathetic tone, demonstrated in the first experiment by the augmented responses to the ganglioplegic hexamethonium (11, 12) , was centrally mediated. Moreover, the reduction observed in the treated animals of the tyramine-sensitive pool of norepinephrine in the sympathetic endings may be related to increased activity of the postganglionic fibers.
In the lead-exposed rats the unchanged cardiovascular effects following phenylephrine or cocaine prove that lead neither significantly affects the reactivity to the stimulation of al-adrenoreceptors nor the neuronal uptake of noradrenaline.
The cardiovascular responses induced by the activation of ,B-adrenoreceptors by isoprenaline and of dopaminergic receptors by dopamine were augmented in lead-exposed rats. It is important to point out that a2-, I3l-, and P2-adrenoreceptors, as well as the dopaminergic receptors, act together to regulate the cyclic nucleotide-dependent availability of calcium for contractile systems (15, 16) . Dibutyryl cAMP, which enters cardiovascular muscle cells, induced reverse effects in the lead-exposed rats. This may be due to a depletion of cAMP produced from ATP due to impairment of the high energy phosphate pathway (14) . On the other hand, it must be pointed out that the altered cAMPdependent availability of Ca2+ for contractile mechanisms in cardiovascular muscle cells was related neither to the phosphodiesterase activity nor to the verapamil-sensitive Ca2+ channels.
This study confirms that chronic lead exposure affects the cardiovascular system, not only by inducing metabolic changes (as those related to the metabolism of calcium or of the high energy phosphate pathway) (7, 14, 16) which are able to produce neurohumoral disorders, but also by inducing neurogenic and humoral effects that may involve the regulation of metabolic processes.
